Identification, Prevalence and Susceptibility Profile of Candida Isolates at the Pasteur Institute in Côte D'ivoire from 2017 to 2019
-
Published:2023-05-08
Issue:2
Volume:6
Page:1-16
-
ISSN:2689-534X
-
Container-title:African Journal of Biology and Medical Research
-
language:en
-
Short-container-title:African Journal of Biology and Medical Research
Author:
A.V. Bonouman Ira,R. Mboh,F. Roger,D. Krasteva,V. Bellet,D. Koffi,J. Noell,C. Pottier,P. Drakulovski,H. Menan,O. Toure,M. Dosso,S. Ranque,S. Bertout
Abstract
This study was conducted in Côte d’Ivoire to determine the respective prevalence of Candida species and to study their susceptibility profile to antifungal agents to identify the emergence of resistance.This retrospective study was conducted from 2017 to 2019 at the Institute Pasteur of Côte d’Ivoire on patients with fungal disease. The yeasts isolated and identified in Côte d’Ivoire were subcultured on a chromogenic medium and identified with MALDI-TOF-MS. Sensitivity tests were performed using the CLSI method and evaluated by the M27. In total, 227 Candida spp. were isolated from 1941 patients. Most of the samples were vaginal swabs (120/228). Using the conventional method, C. albicans was prevalent (52.6%). There were mixtures of 2 to 4 species in 36.8% of the samples. Thus MALDI-TOF-MS identified in 315 isolates 13 distinct species, C. tropicalis was prevalent at 35.2%, and the species in both C. albicans and C. parapsilosis complexes were differentiated. This study highlights the hurdle of correct yeast identification in developing countries. The transition from conventional to modern MALDI-TOF based identification of these life-threatening opportunistic pathogens is mandatory and should be emphasised as a public health priority.
Publisher
African - British Journals
Reference37 articles.
1. [1]. Africa, CWJ., dos Santos Abrantes, PM. (2017). Candida antifungal drug resistance in sub-Saharan African populations: A systematic review. F1000Research 5 :2832. https://doi.org/10.12688/f1000research.10327.2. 2. [2]. Angora, KE., Djohan; V., Ira-Bonouman, VA., Vanga-Bosson, HA., Kassi, KF., Konaté, A., Bedia-Tanoh, VA., Miezan, SA., Kiki-Barro, CP., Menan, H., Touré, AO., and Yavo, W. (2018). Susceptibility of Candida species isolated from recurrent vulvovaginal candidiasis to antifungal agents among women at Institut Pasteur of Côte d’Ivoire. Journal of Yeast and Fungal Research (2018) Vol. 9(3), pp. 21-26. https://doi.org/10.5897/JYFR2018.0185. 3. [3]. Azike, CA., Nwokah, EG., and Abbey, SD. (2018). Molecular Characterization and Phylogeny of Candida Species Isolated from High Vaginal Swab Samples among Patients Presenting with Vulvovaginal Candidiasis in Port Harcourt, Nigeria. European Journal of Biomedical and Pharmaceutical sciences 5(7), 83-89. https://doi.org/ http://www.ejbps.com/ 4. [4]. Bitew, A., & Yeshiwork, A., (2018). Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern. BMC Women's Health 18:94. https://doi.org/10.1186/s12905-018-0607-z 5. [5]. Calderone, RA (2002). Introduction and historical perspectives. Candida and Candidiasis (Calderone R., ed), pp. 15–25. ASM Press, Washington, DC.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|